Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreillon

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Current Opinion in Immunology|August 6, 2003
Innate sensors for Gram-positive bacteriaJoerg R Weber, Philippe Moreillon, Elaine I Tuomanen
Journal of Proteomics|June 11, 2008
Experimental and computational approaches to quantitative proteomics: status quo and outlookAlexandre Panchaud, Michael Affolter, Philippe Moreillon, et al.
The Journal of Antimicrobial Chemotherapy|November 24, 2007
In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogensJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
FEMS Microbiology Letters|February 2, 2006
The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureusPaul A Majcherczyk, Therese McKenna, Philippe Moreillon, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureusJacques Vouillamoz, José M Entenza, Peter Hohl, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococciJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
Revue Medicale De La Suisse Romande|August 6, 2004
[Infective endocarditis: update]Yok-Ai Que, Mauro Oddo, Lucas Liaudet, et al.
International Journal of Antimicrobial Agents|February 27, 2010
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillinJosé M Entenza, Marlyse Giddey, Jacques Vouillamoz, et al.
FEMS Immunology and Medical Microbiology|November 8, 2006
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditisAlain Bizzini, Siham Beggah-Möller, Philippe Moreillon, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2007
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalisPhilippe Moreillon, Walter R Wilson, Roland Leclercq, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Current Opinion in Immunology|August 6, 2003
Innate sensors for Gram-positive bacteriaJoerg R Weber, Philippe Moreillon, Elaine I Tuomanen
Journal of Proteomics|June 11, 2008
Experimental and computational approaches to quantitative proteomics: status quo and outlookAlexandre Panchaud, Michael Affolter, Philippe Moreillon, et al.
The Journal of Antimicrobial Chemotherapy|November 24, 2007
In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogensJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
FEMS Microbiology Letters|February 2, 2006
The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureusPaul A Majcherczyk, Therese McKenna, Philippe Moreillon, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureusJacques Vouillamoz, José M Entenza, Peter Hohl, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococciJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
Revue Medicale De La Suisse Romande|August 6, 2004
[Infective endocarditis: update]Yok-Ai Que, Mauro Oddo, Lucas Liaudet, et al.
International Journal of Antimicrobial Agents|February 27, 2010
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillinJosé M Entenza, Marlyse Giddey, Jacques Vouillamoz, et al.
FEMS Immunology and Medical Microbiology|November 8, 2006
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditisAlain Bizzini, Siham Beggah-Möller, Philippe Moreillon, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2007
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalisPhilippe Moreillon, Walter R Wilson, Roland Leclercq, et al.
Pageof 9